XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Loss Per Common Share
 6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Loss Per Common Share Loss Per Common Share
The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):
For the Three Months Ended June 30,For the Six Months Ended June 30,
2024202320242023
Income (loss) before preferred dividends and accretion of Series A Preferred Stock$1,596 $(34,323)$(15,684)$(54,305)
Dividends and accretion of Series A Preferred Stock(7,979)(7,088)(15,924)(13,364)
Net loss attributable to common shareholders of Evolent Health, Inc.$(6,383)$(41,411)$(31,608)$(67,669)
Weighted-average common shares outstanding - basic and diluted114,688 111,278 114,415 109,540 
Loss per common share
Basic and diluted$(0.06)$(0.37)$(0.28)$(0.62)
Basic net loss per common share is calculated using the weighted average number of common shares outstanding during the period. Diluted net earnings per common share, if any, gives effect to diluted stock options (calculated based on the treasury stock method), shares issuable upon debt conversion (calculated using an as-if converted method).

Anti-dilutive shares excluded from the calculation of weighted-average common shares presented above are presented below (in thousands):
For the Three Months Ended June 30,For the Six Months Ended June 30,
2024202320242023
Restricted stock units ("RSUs"), performance-based RSUs (“PSUs”) and leveraged stock units ("LSUs")533 1,073 854 1,505 
Stock options289 976 351 1,106 
Series A Preferred Stock4,375 4,375 4,375 4,375 
Convertible senior notes20,252 6,188 20,252 6,188 
Total25,449 12,612 25,832 13,174